InFlectis BioScience is a private drug discovery company aiming at targeting.
InFlectis BioScience has raised $650K in total funding. The most recent round was Grant. The last funding was announced in April 2024.
InFlectis BioScience's investors include GO CAPITAL, Remiges Ventures, The ALS Association, National Multiple Sclerosis Society (NMSS), Crédit Mutuel Innovation.
InFlectis BioScience is headquartered in Nantes, France.
InFlectis BioScience is a private drug discovery company aiming at targeting.
InFlectis BioScience is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InFlectis BioScience — Funding & Investors." VCBacked, April 30, 2024, https://www.vcbacked.co/company/inflectis-bioscience. Accessed August 14, 2026.
VCBacked. (2024). InFlectis BioScience — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/inflectis-bioscience
{{cite web |title=InFlectis BioScience — Funding & Investors |url=https://www.vcbacked.co/company/inflectis-bioscience |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated